Skip to main content
Egyptian Rheumatology and Rehabilitation
Download PDF

Articular and skeletal affection in regularly dialyzed patients with end-stage renal disease

Egyptian Rheumatology and Rehabilitation volume 46, pages 162–169 (2019)Cite this article

Abstract

Background

Patients on regular hemodialysis (HD) are vulnerable to develop different articular and skeletal problems that interfere with life quality and affect morbidity and mortality in these patients. To, properly, overcome or even prevent the development of these complications, early detection, especially of the commonly affected parts, is required.

Aim

The aim was to detect articular and skeletal manifestations in patients with end-stage renal disease on regular HD, their relation to duration of dialysis, and which is more affected.

Patients and methods

A total of 50 patients (34 males and 16 females) with end-stage renal disease on regular HD, who were attendants of the dialysis unit of Internal Medicine Department at Al-Azhar University hospital, New Damietta, with duration of dialysis ranging between 3 and 15 years and age ranging from 26 to 70 years old were recruited for the study. They were classified into three groups: group I: mild, group II: moderate, and group III: severe joint affection. Full history taking, thorough clinical examination, especially for uremic and rheumatologic manifestations; laboratory investigations (inflammatory and metabolic markers); synovial fluid analysis and culture; and radiological investigations (radiography, dual-energy X-ray absorptiometry scan, ultrasound, computed tomography, and MRI of the affected parts) were done.

Results

There was a significant association between the duration of dialysis and the presence of joint affection. The most common affected joints were knee joints [n=23 patients (46%)] and shoulder joints [n=10 (20%)]. There was a statistically significant association between the severity of joints involvement and the prolonged duration of dialysis. The most common crystals present were the urate crystals (26%) followed by calcium pyrophosphate dihydrate (12%), and lastly oxalate crystals (8%). Carpal tunnel syndrome was diagnosed in 12 patients, with high significant association between the duration of dialysis and presence of carpal tunnel syndrome. There was increase in the level of parathyroid hormone with increase in the duration of renal dialysis. Moreover, 64% of patients had hyperparathyroid bone disease. The mean alkaline phosphatase level was increased in all groups of patients but was more in patients with severe joint affection. Serum albumin was maintained within normal level in HD patients. Radiological study of our HD patients showed that the most frequent radiological findings were signs of secondary hyperparathyroidism (subperiosteal resorption; acroosteolysis in the terminal tufts; pathological fracture, with two fractures in the spine, one in the neck of femur, and one fracture in the rib; and periarticular calcification, with one was found in the hand, and two were found in the pelvis). The incidence of these radiological findings increased with the increase of duration of HD. In addition, 18 patients had normal bone mineral density values, 18 patients had osteopenia, whereas 14 patients had osteoporosis.

Conclusion

The increased duration of dialysis is associated with increased incidence of articular and skeletal complications mainly renal osteodystrophy in the form of crystal-induced arthritis, osteoporosis, and periarticular calcification. Knee and shoulder joints, spine, neck of femur, wrist joints, and ribs are the main targets for complications and then for proper prophylaxis.

References

  1. Abella V, Scotece M, Conde J, López V, Lazzaro V, Pino J, et al. Adipokines, metabolic syndrome and rheumatic diseases. J Immunol Res 2014; 2014:343746.

    Article  Google Scholar 

  2. Paola A, Germano G, Mantovani A. Molecular links between inflammation and cancer. Syst Biol Cancer 2015; 1:273–281.

    Google Scholar 

  3. Allon M. Evidence-based cardiology in hemodialysis patients. J Am Soc Nephrol 2013; 24:1934–1943.

    Article  CAS  Google Scholar 

  4. Weir MA, Herzog CA. Beta blockers in patients with end-stage renal disease − evidence-based recommendations. Semin Dial 2018; 31:219–225.

    Article  Google Scholar 

  5. Rolvien T, Krause M, Jeschke A, Yorgan T, Püschel K, Schinke T, et al. Vitamin D regulates osteocyte survival and perilacunar remodeling in human and murine bone. Bone 2017; 103:78–87.

    Article  CAS  Google Scholar 

  6. Aranzi GC, Test AVL, Test BVR, et al. RD 4 Addenbrooke’s Cognitive Examination 101 Alzheimer’s disease clinical assessment histological imaging. Dementia 2014; 98:99.

    Google Scholar 

  7. Asamiya Y, Tsuchiya K, Nitta K. Role of sclerostin in the pathogenesis of chronic kidney disease-mineral bone disorder. Renal Replacement Ther 2016; 2:1.

    Article  Google Scholar 

  8. Chen NX, O’Neill KD, Allen MR, Newman CL, Moe SM. Low bone turnover in chronic kidney disease is associated with decreased VEGF-A expression and osteoblast differentiation. Am J Nephrol 2015; 41:464–473.

    Article  CAS  Google Scholar 

  9. Demer LL, Tintut Y. Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscl Thromb Vasc Biol 2014; 34:715–723.

    Article  CAS  Google Scholar 

  10. Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 2014; 73:62–68.

    Article  Google Scholar 

  11. Breivik H. Fifty years on the visual analogue scale (VAS) for pain-intensity is still good for acute pain. But multidimensional assessment is needed for chronic pain. Scand J Pain 2016; 11:150–152.

    PubMed  Google Scholar 

  12. O’Neill S, Jaszczak SLT, Steffensen AKS, Debrabant B. Using 4+ to grade near-normal muscle strength does not improve agreement. Chiropr Man Therap 2017; 25:28.

    Article  Google Scholar 

  13. Firestein GS, Budd R, Gabriel SE, McInnes IB, O’Dell JR. Kelley’s textbook of rheumatology. 9th ed., ISBN: 978-1-4377-1738-9, 2013;563.

  14. Creamer P, Lethbridge-Cejku M, Hochberg MC. Factors associated with functional impairment in symptomatic knee osteoarthritis. Rheumatology 2000; 39:490.

    Article  CAS  Google Scholar 

  15. Craig KW, Stevermer JJ. DEXA screening − are we doing too much? J Fam Pract 2012; 61:555–556.

    PubMed  PubMed Central  Google Scholar 

  16. Christopher KJ, Duan X, Michael ES. Inherited neuropathies: clinical overview and update. Muscle Nerve 2013; 48:604–622.

    Article  Google Scholar 

  17. Damian DG. The parathyroid hormone family of ligands and receptors. AIMS Med Sci 2015; 2:118–130.

    Article  Google Scholar 

  18. Rodríguez-Henríquez P, Solano C, Peña A, León-Hernández S, Hernández-Díaz C, Gutiérrez M, et al. Sternoclavicular joint involvement in rheumatoid arthritis: clinical and ultrasound findings of a neglected joint. Arthritis Care Res (Hoboken) 2013; 65:1177–1182.

    Article  Google Scholar 

  19. Hoshino J, Yamagata K, Nishi S, Nakai S, Masakane I, Iseki K, Tsubakihara Y. Significance of the decreased risk of dialysis-related amyloidosis now proven by results from Japanese nationwide surveys in 1998 and 2010. Nephrol Dial Transplant 2015; 31:595–602.

    Article  Google Scholar 

  20. Miyata T, Suzuki N, van Ypersele de Strihou C. Diabetic nephropathy: are there new and potentially promising therapies targeting oxygen biology. Kidney Int 2013; 84:693–702.

    Article  CAS  Google Scholar 

  21. Hazenberg BP. Amyloidosis: a clinical overview. Rheum Dis Clin North Am 2013; 39:323–345.

    Article  Google Scholar 

  22. Isaka Y, Takabatake Y, Takahashi A, Saitoh T, Yoshimori T. Hyperuricemia-induced inflammasome and kidney diseases. Nephrol Dial Transplant. 2016; 31:890–896.

    Article  CAS  Google Scholar 

  23. Legendre CM, Licht C,Muus P,Greenbaum LA, Babu S, Bedrosian C, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 2013; 368:2169–2181.

    Article  CAS  Google Scholar 

  24. Mason LW, Iqroop C, KhitishMohanty C. The percutaneous stabilization of the sacroiliac joint with hollow modular anchorage screws: a prospective outcome study. Euro Spine J 2013; 22:2325–2331.

    Article  Google Scholar 

  25. Blumenkrantz D, Roberts KL, Shelton H, Lycett S, Barclay WS. The short stalk length of highly pathogenic avian influenza H5N1 virus neuraminidase limits transmission of pandemic H1N1 virus in ferrets. J Virol 2013; 87:10539–10551.

    Article  CAS  Google Scholar 

  26. Kaysen GA, Chin A. If oxidative stress is an appropriate and specific target, what reagent should we choose? J Am Soc Nephrol 2014; 25:427–429.

    Article  CAS  Google Scholar 

  27. Rocco MV. Does more frequent hemodialysis provide dietary freedom? J Ren Nutr 2013; 23:259–262.

    Article  Google Scholar 

  28. Ureña P, Bernard-Poenaru O, Ostertag A, Baudoin C, Cohen-Solal M, Cantor R, de Veejoul MC. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 2003; 18:2325–2331.

    Article  Google Scholar 

  29. Negri AL, Brandenburg VM. Calcitriol resistance in hemodialysis patients with secondary hyperparathyroidism. Int Urol Nephrol 2014; 46:1145–1151.

    Article  CAS  Google Scholar 

  30. Gerakis A, Hutchison AJ, Apostolou T, Freemont AJ. Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis. Nephrol Dial Transplant 1996; 11: 2430–2438.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Al-Azhar University, New Damietta, Egypt

    Hisham E. Abd El Wahab & Tarek M. Abd Elaziz

  2. Department of Internal Medicine, Faculty of Medicine, Al-Azhar University, New Damietta, Madinat Dmyat Al-Jdydh, 1105, Egypt

    Mohammad M. Alsayyad MD & Mahmoud S. Berengy

Authors
  1. Hisham E. Abd El Wahab
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tarek M. Abd Elaziz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammad M. Alsayyad MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mahmoud S. Berengy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohammad M. Alsayyad MD.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abd El Wahab, H.E., Abd Elaziz, T.M., Alsayyad, M.M. et al. Articular and skeletal affection in regularly dialyzed patients with end-stage renal disease. Egypt Rheumatol Rehabil 46, 162–169 (2019). https://doi.org/10.4103/err.err_57_18

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/err.err_57_18

Keywords